Skip to content
Main Menu
Corporate
About Femasys
Who we are
Leadership
Investor Relations
Overview
News
Events & Presentations
Stock Info
Financials
Governance
Resources
Resources
Contact Us
Contact Femasys
Join Us
Healthcare Professionals
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis
Patients
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis
Search
Search
Resources
Find the latest news about Femasys, including our media mentions, scientific publications, and more.
All
2021
2022
2023
2024
Video
04/16/2024
Kathy Lee-Sepsick on Wharton Business Daily
Wharton Business Daily
04/05/2024
Femasys is committed to providing women with revolutionary healthcare products: CEO
AlphaStreet
04/02/2024
Bloomberg Businessweek: Medical Tech for Women
Bloomberg
03/21/2024
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
GlobeNewswire
03/20/2024
FemaSeed Shows Positive Results for Infertility Treatment
Contemporary OB/GYN
03/20/2024
FemaSeed: A Breakthrough Solution Proving Promise in Overcoming Infertility Challenges
CSIMarket
Load More
12/20/2021
Femasys Creates Products and Procedures for the Fallopian Tubes
FemTech Focus Podcast
12/20/2021
Advancements in Technologies Changing Reproductive Healthcare with Kathy Lee-Sepsick
Empowered Patient Podcast
10/15/2021
Femasys Inc: Putting the Focus on Women’s Reproductive Health
Benchtop Bios
07/15/2021
Femasys: Revolutionizing Female Reproduction (NASDAQ:FEMY)
Seeking Alpha
06/28/2021
Anne Morrissey Joins Femasys as a New Board Member to Help Advance FEMASEED into Clinical Development
Femtech Insider
05/17/2021
Women’s Health Company Femasys Files for $40M IPO
Femtech Insider
11/03/2022
Femasys Targets Male Infertility with Updated Trial Design
BioWorld
10/20/2022
Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement
GlobeNewswire
10/12/2022
Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs
GlobeNewswire
10/06/2022
Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control
GlobeNewswire
09/29/2022
Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team
GlobeNewswire
09/08/2022
Tech Companies Working On Contraception Face A New Landscape After Roe
Buzzfeed News
Load More
12/15/2023
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine
GlobeNewswire
11/30/2023
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
GlobeNewswire
11/28/2023
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
GlobeNewswire
11/15/2023
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
GlobeNewswire
04/13/2023
FemCerv®: Well-designed technology that can minimize patient discomfort
MDedge
02/22/2023
The Post-Roe Fertility Journey
SXSW
Load More
04/16/2024
Kathy Lee-Sepsick on Wharton Business Daily
Wharton Business Daily
04/05/2024
Femasys is committed to providing women with revolutionary healthcare products: CEO
AlphaStreet
04/02/2024
Bloomberg Businessweek: Medical Tech for Women
Bloomberg
03/21/2024
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
GlobeNewswire
03/20/2024
FemaSeed Shows Positive Results for Infertility Treatment
Contemporary OB/GYN
03/20/2024
FemaSeed: A Breakthrough Solution Proving Promise in Overcoming Infertility Challenges
CSIMarket
Load More
08/12/2022
VIDEO: President and CEO, Kathy Lee-Sepsick speaks to connecting with the audience
YouTube
08/12/2022
VIDEO: President and CEO, Kathy Lee-Sepsick at SLS
YouTube
07/28/2022
VIDEO: Femasys KOL Event
YouTube
Media Kits
For additional information, please email
[email protected]
Corporate Kit
Infertility Kit
Contraception Kit
Biopsy Kit
Main Menu
Corporate
About Femasys
Who we are
Leadership
Investor Relations
Overview
News
Events & Presentations
Stock Info
Financials
Governance
Resources
Resources
Contact Us
Contact Femasys
Join Us
Healthcare Professionals
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis
Patients
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis